Man Group’s Neuronetics STIM Stock Holding History

Man Group’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,606	Closed	-$93.5K	–	2241
2022 Q4	$93.5K	Buy	+13,606	New	+$64.2K	﹤0.01%	1918

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Man Group's STIM Position: Q1 2023 in Review

Man Group sold out of Neuronetics (STIM) in Q1 2023, closing a stake of 13,606 shares — an estimated $93.5K sold.

Man Group first reported a position in STIM in Q4 2022 and held it in 1 quarter. The position peaked at $93.5K in Q4 2022. 74 funds tracked by Wall St. Rank hold STIM as of Q1 2023.

Man Group reported no remaining Neuronetics position as of Q1 2023 after selling out during the quarter.
Man Group sold 13,606 Neuronetics shares in Q1 2023, an estimated $93.5K.
Man Group first reported a position in Neuronetics in Q4 2022 and held it in 1 quarter.
Man Group's Neuronetics position peaked at $93.5K in Q4 2022.
74 funds tracked by Wall St. Rank held Neuronetics as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.